Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
Due to the unpredictable course and heterogenous treatment response in multiple sclerosis (MS), there is a clear need for biomarkers that reflect disease activity in the clinical follow-up of these patients. Neurofilaments are neuron-specific components of the cytoskeleton that can be assayed in dif...
Main Authors: | Kristin N. Varhaug, Øivind Torkildsen, Kjell-Morten Myhr, Christian A. Vedeler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00338/full |
Similar Items
-
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
by: Egil Røsjø, et al.
Published: (2020-04-01) -
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
by: Aidong Yuan, et al.
Published: (2021-09-01) -
DTI PARAMETER CHANGES IN AXONAL LOSS DUE TO MULTIPLE SCLEROSIS
by: A. Roceanu, et al.
Published: (2011-06-01) -
Dietary vitamin D3 supplements reduce demyelination in the cuprizone model.
by: Stig Wergeland, et al.
Published: (2011-01-01) -
Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs
by: Taesik Yun, et al.
Published: (2021-07-01)